EPKINLY vs MONJUVI

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. EPKINLY and MONJUVI are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EPKINLY	MONJUVI
Rating	New	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	EPCORITAMAB-BYSP	TAFASITAMAB-CXIX
Manufacturer	Genmab US, Inc.	Morphosys US Inc
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Diffuse Large B-Cell Lymphoma	Diffuse Large B-Cell Lymphoma

epkinly monjuvi

Rating

New

Pharmacy pays

—

Type

Active ingredient

EPCORITAMAB-BYSP

TAFASITAMAB-CXIX

Manufacturer

Genmab US, Inc.

Morphosys US Inc

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Diffuse Large B-Cell Lymphoma

Frequently asked questions

What is the difference between Epkinly and Monjuvi?

Epkinly contains Epcoritamab-Bysp, while Monjuvi contains Tafasitamab-Cxix — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.